Reneo Pharmaceuticals Competitors and Similar CompaniesClear all

Reneo Pharmaceuticals's competitors and similar companies include Grindeks, FinVector, Selonterra and IntraBio.

	Reneo Pharmaceuticals Reneo Pharmaceuticals is a pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases.	Grindeks Grindeks, a pharmaceutical company, engages in the research, development, manufacture, and sale of generics and active pharmaceutical ingredients.	FinVector FinVector is a company engaged in the research and development of gene and cell therapies.	Selonterra Selonterra is a company that develops therapeutics for Alzheimer's and Parkinson's diseases.	IntraBio IntraBio is a biopharmaceutical company that develops therapies for genetic and neurodegenerative diseases.
Founding Date	Founding Date 2018	Founding Date 1991	Founding Date 2013	Founding Date 2017	Founding Date 2015
Type	Type Subsidiary	Type Private	Type Private	Type Private	Type Private
Tags	Tags Healthcare drug development genetics pharma therapy	Tags Healthcare drug development genetics pharma therapy	Tags Healthcare drug development genetics pharma therapy	Tags Healthcare drug development genetics pharma therapy	Tags Healthcare biotech drug development genetics pharma therapy
Locations	Locations San Diego, US HQ Sandwich, GB Irvine, US	Locations Rīga, LV HQ Yerevan, AM Bakı, AZ Minsk, BY Tallinn, EE Tbilisi, GE Almaty, KZ see more	Locations Kuopio, FI HQ	Locations San Mateo, US HQ	Locations Begbroke, GB HQ
Employees	Employees 46475% increase	Employees 1,505	Employees 338	Employees 3	Employees 4
Financial
Net income	Net income ($59.5m) (FY, 2025)	Net income €13.5m (FY, 2019)	Net income N/A	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised $ 145m	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 4.9m